These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26314501)

  • 1. Editorial: 21st Century Storm Chasers: Defining Macrophage Activation Syndrome.
    Canna SW; Nigrovic PA
    Arthritis Rheumatol; 2016 Mar; 68(3):557-60. PubMed ID: 26314501
    [No Abstract]   [Full Text] [Related]  

  • 2. [Macrophage activation syndrome in a patient with systemic type juvenile idiopathic arthritis].
    Qiu JJ; Wei M
    Zhonghua Er Ke Za Zhi; 2005 Nov; 43(11):874-5. PubMed ID: 16316546
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of macrophage activation syndrome due to systemic onset juvenile idiopathic arthritis with antithymocyte globulin.
    Ozturk K; Ekinci Z
    Rheumatol Int; 2015 Oct; 35(10):1779-80. PubMed ID: 26210998
    [No Abstract]   [Full Text] [Related]  

  • 4. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ;
    Ann Rheum Dis; 2016 Mar; 75(3):481-9. PubMed ID: 26865703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ;
    Arthritis Rheumatol; 2016 Mar; 68(3):566-76. PubMed ID: 26314788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 50 Years Ago in TheJournalofPediatrics: Hepatic Dysfunction in Systemic Juvenile Idiopathic Arthritis with Alleviation of Arthritis: The First Description of Macrophage Activation Syndrome?
    Ashkenazi L; Hashkes PJ
    J Pediatr; 2021 Jul; 234():64. PubMed ID: 34172168
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrophage activation syndrome: Experience in the questioned role of etoposide.
    Conde LF; Aedo KP; Miraval-Niño de Guzmán T
    Reumatol Clin; 2017; 13(4):239-240. PubMed ID: 28041909
    [No Abstract]   [Full Text] [Related]  

  • 8. A 17-year-old girl with severe respiratory failure and circulatory shock.
    Gutierrez D; Guy L; Katikireddi VS; Butler JP; Gowardman J
    Med J Aust; 2011 Oct; 195(7):414-5. PubMed ID: 21978351
    [No Abstract]   [Full Text] [Related]  

  • 9. FDG-PET in macrophage activation syndrome associated with systemic juvenile idiopathic arthritis.
    Shimizu M; Ikawa Y; Mizuta M; Takakura M; Inoue N; Nishimura R; Yachie A
    Pediatr Int; 2017 Apr; 59(4):509-511. PubMed ID: 28401744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis].
    Tavares AC; Ferreira GA; Guimarães LJ; Guimarães RR; Santos FP
    Rev Bras Reumatol; 2015; 55(1):79-82. PubMed ID: 25575650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic juvenile idiopathic arthritis: a review.
    Hay AD; Ilowite NT
    Pediatr Ann; 2012 Nov; 41(11):. PubMed ID: 23814932
    [No Abstract]   [Full Text] [Related]  

  • 12. Occult macrophage activation syndrome in systemic-onset juvenile idiopathic arthritic syndrome--a case report.
    Zeng P; Li F; Zeng H
    Acta Reumatol Port; 2013; 38(3):196-200. PubMed ID: 24149017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Juvenile Idiopathic Arthritis.
    Lee JJY; Schneider R
    Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
    Wagner-Weiner L
    Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation syndrome as a complication of juvenile rheumatoid arthritis.
    An Q; Jin MW; An XJ; Xu SM; Wang L
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4322-4326. PubMed ID: 29077164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis?
    Han SB; Lee SY; Jeong DC; Kang JH
    Ann Rheum Dis; 2016 Jul; 75(7):e44. PubMed ID: 26965982
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma exchange successfully treated macrophage activation syndrome in rheumatoid factor-positive polyarticular juvenile idiopathic arthritis with co-existing pneumonia.
    Shi L; Hu F; Xu C; Zhu H; Qie D; Yuan C; Tao Y; Liu H
    Int J Rheum Dis; 2018 May; 21(5):1142-1145. PubMed ID: 28328098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
    Yokota S; Itoh Y; Morio T; Sumitomo N; Daimaru K; Minota S
    J Rheumatol; 2015 Apr; 42(4):712-22. PubMed ID: 25684767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.